Literature DB >> 2674862

Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis.

L J Harrison1, G W Joshua, S H Wright, R M Parkhouse.   

Abstract

A mouse monoclonal antibody (MoAb), reactive with a repetitive carbohydrate epitope on lentil-lectin adherent glycoproteins present on the surface and in the secretions of Taenia saginata cysticerci, was used in the construction of a diagnostic ELISA assay to detect these glycoproteins in the serum of T. saginata infected cattle. The MoAb was used as the trapping layer and subsequently bound glycoprotein was revealed using the same MoAb and biotinylated peroxidase-streptavidin complex as the developing system. The assay was suitably specific. Exceptionally low background values were obtained with sera from animals with a range of commonly occurring tropical parasitic infections, including Taenia hydatigena, Echinococcus granulosus and Fasciola gigantica. The minimal detection level was approximately 200 live cysticerci in cattle. Parasite derived glycoprotein could be detected in serum from about 4-5 weeks post-infection onwards and was associated with a current infection, as drug treatment of infected cattle to kill the cysticerci resulted in the disappearance of these components from the circulation, while the titre of anti-parasite antibody remained high. The same assay also detected Taenia solium cysticercosis in humans.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674862     DOI: 10.1111/j.1365-3024.1989.tb00673.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  42 in total

1.  A Novel, Highly Sensitive Quantitative Polymerase Chain Reaction Assay for the Diagnosis of Subarachnoid and Ventricular Neurocysticercosis and for Assessing Responses to Treatment.

Authors:  Elise M O'Connell; Sarah Harrison; Eric Dahlstrom; Theodore Nash; Thomas B Nutman
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

Review 2.  Laboratory Diagnosis of Neurocysticercosis (Taenia solium).

Authors:  Hector H Garcia; Seth E O'Neal; John Noh; Sukwan Handali
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 3.  Prevention and control of Taenia solium taeniasis/cysticercosis in Peru.

Authors:  Robert H Gilman; Armando E Gonzalez; Fernando Llanos-Zavalaga; Victor C W Tsang; Hector H Garcia
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

4.  Ag-ELISA and PCR for monitoring the vaccination of cattle against Taenia saginata cysticercosis using an oncospheral adhesion protein (HP6) with surface and secreted localization.

Authors:  L J S Harrison; T Garate; D M Bryce; L M Gonzalez; M Foster-Cuevas; L W Wamae; J A Onyango-Abuje; R M E Parkhouse
Journal:  Trop Anim Health Prod       Date:  2005-02       Impact factor: 1.559

Review 5.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

6.  Evidence that active transmission of porcine cysticercosis occurs in Venezuela.

Authors:  Maria M Cortez Alcobedes; Gonzalo Boggio; Ma de Lourdes Guerra; Magda Rodríguez de Gavidia; Glenda C Rojas Reyes; Elizabeth Ferrer; Maria Lares; Yenny Alviarez; Leslie J S Harrison; R Michael E Parkhouse
Journal:  Trop Anim Health Prod       Date:  2009-09-25       Impact factor: 1.559

Review 7.  Studies on helminthosis at the Centre for Tropical Veterinary Medicine (CTVM).

Authors:  L J Harrison; J A Hammond; M M Sewell
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

8.  Control of Taenia saginata by post-mortem examination of carcasses.

Authors:  W Wanzala; J A Onyango-Abuje; E K Kang'ethe; K H Zessin; N M Kyule; M P O Baumann; H Ochanda; L J S Harrison
Journal:  Afr Health Sci       Date:  2003-08       Impact factor: 0.927

9.  Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.

Authors:  Silvia Rodriguez; Pierre Dorny; Victor C W Tsang; E Javier Pretell; Jef Brandt; Andres G Lescano; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

10.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.